Home
/
Conditions
/ Gout
Metabolic and Inflammatory Health
Schedule a Consultation
Gout
Gout is not just a joint disease. It is a metabolic disease driven by hyperuricemia, insulin resistance, and renal uric acid handling that produces inflammatory crystal deposition in joints, kidneys, and cardiovascular tissue. Conventional treatment manages acute attacks with colchicine and NSAIDs and lowers uric acid with allopurinol. Functional medicine addresses the metabolic drivers producing the hyperuricemia: fructose metabolism, insulin resistance, purine overproduction, and renal excretion failure, treating the systemic metabolic disease rather than just the joint inflammation.
Metabolic HealthUric Acid and InsulinSystemic Metabolic Disease
9.2 MillionAmericans affected by gout, with prevalence doubling over the past two decades
Metabolicgout is a metabolic disease driven by insulin resistance, not just a joint condition
Preventableaddressing the metabolic drivers eliminates flares and reduces cardiovascular risk simultaneously
← Back to Conditions
Condition: Gout | Category: Metabolic and Inflammatory Health | Reviewed by: Brian Lamkin, DO
What Is Gout?
Gout is an inflammatory arthritis caused by the deposition of monosodium urate (MSU) crystals in joints and periarticular tissues. When serum uric acid exceeds its saturation point (approximately 6.8 mg/dL), urate crystallizes in the synovial fluid of joints, producing intense inflammatory attacks characterized by severe pain, swelling, redness, and heat, classically affecting the first metatarsophalangeal joint (big toe) but also the ankle, knee, wrist, and fingers.
Gout affects approximately 9.2 million Americans, and its prevalence has doubled over the past two decades, paralleling the rise of metabolic syndrome, obesity, and high-fructose corn syrup consumption. This correlation is not coincidental. Gout is fundamentally a metabolic disease. Approximately 90 percent of hyperuricemia results from impaired renal uric acid excretion, not from overproduction. Insulin resistance upregulates the URAT1 transporter in the proximal renal tubule, reabsorbing uric acid back into the bloodstream rather than excreting it. This mechanism directly links gout to the same metabolic dysfunction that produces type 2 diabetes, hypertension, and cardiovascular disease.
Key principle: Gout is not a dietary indulgence disease. It is a metabolic disease in which insulin resistance impairs the kidney's ability to excrete uric acid. Fructose metabolism (from high-fructose corn syrup, sucrose, and fruit juice) produces uric acid through ATP degradation in the liver. Treating gout requires addressing both the renal excretion failure (insulin sensitization) and the production excess (fructose elimination), not just lowering the uric acid number with medication.
Why Gout Matters
Beyond Joint Pain
- Cardiovascular risk: hyperuricemia is an independent cardiovascular risk factor. Uric acid produces endothelial dysfunction, activates the NLRP3 inflammasome, and promotes vascular inflammation. Gout patients have significantly elevated rates of heart attack, stroke, and cardiovascular mortality
- Renal disease: urate crystal deposition in the kidneys produces uric acid nephropathy, kidney stones, and progressive renal insufficiency
- Metabolic syndrome marker: gout co-occurs with insulin resistance, hypertension, dyslipidemia, and visceral adiposity at rates far exceeding chance. It is a clinical indicator of underlying metabolic dysfunction
- Chronic tophaceous gout: untreated chronic hyperuricemia produces tophi (visible urate deposits) in joints, tendons, and soft tissues that cause permanent structural damage and disability
Why Standard Treatment Is Incomplete
- Acute treatment without metabolic evaluation: colchicine and NSAIDs manage the flare but do not address the hyperuricemia or the metabolic disease producing it
- Urate-lowering therapy without insulin assessment: allopurinol reduces uric acid production but does not address the renal excretion failure driven by insulin resistance. Fasting insulin is not part of standard gout evaluation
- Dietary advice is incomplete: "avoid red meat and beer" addresses only a fraction of the purine and fructose burden. High-fructose corn syrup and fruit juice are stronger drivers of hyperuricemia than dietary purines
- Cardiovascular risk is not proactively managed: gout is treated as a rheumatologic condition without recognition that the same metabolic dysfunction is producing cardiovascular disease that requires concurrent evaluation
Common Symptoms
Acute Flare
- Severe joint pain (often big toe)
- Rapid onset (peak within 12 to 24 hours)
- Joint swelling, redness, and heat
- Exquisite tenderness (cannot bear touch)
Intercritical and Chronic
- Recurrent attacks with increasing frequency
- Multiple joints affected over time
- Tophi (visible urate deposits)
- Joint stiffness between attacks
Metabolic Signals
- Concurrent hypertension
- Elevated triglycerides
- Visceral adiposity
- Blood sugar instability
Root Causes: A Functional Medicine Perspective
Hyperuricemia is the result of an imbalance between uric acid production and excretion. Both sides have identifiable, modifiable drivers.
Insulin Resistance and Renal Urate Excretion
Insulin resistance is the most consequential and most overlooked mechanism in gout. Hyperinsulinemia upregulates the URAT1 transporter in the proximal renal tubule, increasing uric acid reabsorption and decreasing excretion. This directly links gout to metabolic syndrome. The patient with gout, hypertension, elevated triglycerides, and visceral adiposity has a single upstream metabolic driver: insulin resistance is producing all of these conditions simultaneously through different downstream pathways.
Fructose Metabolism
Fructose is unique in its metabolism. When fructose is phosphorylated in the liver by fructokinase, it rapidly depletes ATP. The resulting AMP is degraded through the purine pathway (AMP to IMP to hypoxanthine to xanthine to uric acid), producing uric acid as a direct metabolic byproduct. This mechanism makes high-fructose corn syrup, sucrose (50 percent fructose), and concentrated fruit juice more potent drivers of hyperuricemia than dietary purines from meat. A 12-ounce soda produces more uric acid than a serving of organ meat.
Purine Overload and Alcohol
Dietary purines from organ meats, shellfish, and certain fish contribute to uric acid production through xanthine oxidase-mediated conversion. Beer contains both purines (from brewer's yeast) and alcohol (which impairs renal uric acid excretion and increases purine turnover). Spirits impair excretion without the purine contribution. Wine has the weakest association with gout of all alcoholic beverages.
Medication and Renal Factors
Thiazide and loop diuretics impair renal uric acid excretion, producing iatrogenic hyperuricemia that triggers gout in susceptible patients. Low-dose aspirin (below 1g) reduces uric acid excretion. Cyclosporine and tacrolimus produce hyperuricemia through renal effects. Chronic kidney disease progressively reduces uric acid clearance capacity.
Conventional vs Functional Medicine Approach
| Domain | Conventional Medicine | Functional Medicine |
|---|---|---|
| Acute | Colchicine, NSAIDs, corticosteroids | Same acute management plus anti-inflammatory support (quercetin, bromelain, cherry concentrate) |
| Prevention | Allopurinol or febuxostat; "avoid purines" | Insulin sensitization, fructose elimination, cherry concentrate, vitamin C, hydration, urate-lowering therapy when indicated |
| Metabolic | Not systematically evaluated | Fasting insulin, HOMA-IR, triglyceride/HDL ratio, comprehensive metabolic assessment |
| Cardiovascular | Not connected to gout management | Proactive cardiovascular risk assessment alongside gout treatment because the metabolic driver is shared |
Key Labs to Evaluate
Fasting InsulinInsulin resistance is the primary driver of impaired renal uric acid excretion in the majority of gout patients.
→Triglyceride/HDL RatioThe best standard panel surrogate for insulin resistance and metabolic syndrome severity.
→hs-CRPSystemic inflammation from urate crystal deposition and NLRP3 inflammasome activation.
→HbA1cGlycemic control reflecting the metabolic syndrome environment that produces hyperuricemia.
→Fasting GlucoseBaseline glycemic marker alongside insulin for HOMA-IR calculation and metabolic syndrome assessment.
→How to Interpret These Labs Together
Elevated uric acid with elevated fasting insulin, elevated triglycerides, and low HDL identifies the insulin resistance-driven gout pattern. Hyperinsulinemia is directly impairing renal uric acid excretion through URAT1 upregulation. Insulin sensitization improves renal uric acid clearance, reduces triglycerides, and addresses the cardiovascular risk that the same metabolic dysfunction is producing. This is the most common and most consequential pattern in gout.
Recurrent gout flares with normal fasting insulin but high fructose intake identifies the fructose-driven overproduction pattern. Fructose metabolism is producing excessive uric acid through ATP degradation, overwhelming excretion capacity. Fructose elimination (high-fructose corn syrup, sucrose, fruit juice) reduces production at the metabolic source. Cherry concentrate provides natural xanthine oxidase inhibition.
Common Patterns Seen in Patients
- The patient on allopurinol with persistent flares and metabolic syndrome: uric acid reduced from 9.2 to 6.1 on allopurinol 300mg. Still having 2 to 3 flares per year. Fasting insulin 22. TG/HDL ratio 4.8. BMI 32. The allopurinol reduced uric acid production but the insulin resistance is still impairing excretion and the fructose intake is still driving production. Insulin sensitization, fructose elimination, and cherry concentrate alongside allopurinol eliminated flares and improved metabolic markers simultaneously.
- The patient whose gout started when they began a diuretic: new onset gout 6 months after starting hydrochlorothiazide for hypertension. Thiazide diuretics impair renal uric acid excretion. The gout was iatrogenic. Switching to a non-diuretic antihypertensive (losartan, which actually lowers uric acid) resolved the hyperuricemia. Concurrent blood pressure optimization through metabolic intervention.
- The 32-year-old with gout drinking 3 sodas per day: young onset gout. No family history. BMI 28. Fasting insulin 16. Three 20-ounce sodas daily (approximately 195g fructose/day from HFCS). The fructose is producing massive uric acid through ATP degradation in the liver, and the resulting insulin resistance is impairing excretion. Soda elimination alone reduced uric acid from 8.4 to 5.9 over 3 months without medication. Flares ceased.
Treatment and Optimization Strategy
Metabolic Gout Management
Metabolic and Dietary
- Fructose elimination: remove high-fructose corn syrup, sucrose-sweetened beverages, and concentrated fruit juice. The single most impactful dietary change for uric acid reduction
- Insulin sensitization: time-restricted eating, reduced refined carbohydrates, resistance training, berberine. Improves renal uric acid excretion by reducing insulin-mediated URAT1 upregulation
- Cherry concentrate (tart cherry, 500mg twice daily): natural xanthine oxidase inhibition and anti-inflammatory anthocyanins. Documented to reduce gout flare frequency by 35 percent
- Vitamin C (500mg to 1g daily): enhances renal uric acid excretion through competitive inhibition of urate reabsorption. Documented to lower uric acid by 0.5 to 1.0 mg/dL
Medical and Anti-Inflammatory
- Allopurinol or febuxostat: xanthine oxidase inhibitors for urate-lowering when metabolic intervention alone is insufficient to maintain uric acid below 6.0 mg/dL
- Quercetin (500mg twice daily): natural xanthine oxidase inhibitor with anti-inflammatory properties. May reduce the effective dose of allopurinol needed
- Omega-3 fatty acids (2 to 3g EPA+DHA): anti-inflammatory support reducing NLRP3 inflammasome activation from urate crystals
- Hydration (2.5 to 3L daily): maintains uric acid in solution and supports renal excretion. Alkalinizing the urine (potassium citrate) further improves urate solubility
What Most Doctors Miss
- Insulin resistance is the primary driver of hyperuricemia: 90 percent of hyperuricemia is from under-excretion, not overproduction. Insulin resistance through URAT1 upregulation is the most common mechanism. Fasting insulin is not part of standard gout evaluation.
- Fructose is a stronger driver than dietary purines: high-fructose corn syrup produces more uric acid through ATP degradation than dietary purines from meat. The "avoid red meat" advice addresses a secondary contributor while ignoring the primary one.
- Gout is a cardiovascular risk marker: hyperuricemia independently predicts cardiovascular events. The patient with gout should receive the same cardiovascular risk assessment as the patient with a family history of heart disease, because the metabolic driver is the same.
- Diuretics cause gout: thiazide and loop diuretics impair renal uric acid excretion. Every patient who develops gout on a diuretic should have the medication reconsidered.
When to Seek Medical Care
If you experience recurrent acute joint inflammation (particularly in the big toe, ankle, or knee), have been diagnosed with hyperuricemia, have metabolic syndrome components (hypertension, dyslipidemia, visceral adiposity), or have gout that recurs despite allopurinol, a comprehensive metabolic evaluation including fasting insulin and cardiovascular risk assessment is warranted alongside standard gout management.
Recommended Testing
Gout evaluation identifies the metabolic mechanisms producing hyperuricemia and the cardiovascular risk that the same metabolic dysfunction is driving.
Uric Acid and Renal
- Serum Uric Acid
- BUN, Creatinine, eGFR
- 24-hour Urine Uric Acid (if indicated)
Metabolic
- Fasting Insulin / HOMA-IR
- Triglyceride/HDL Ratio
- HbA1c, Fasting Glucose
- hs-CRP
- Lipid Panel
Need cardiovascular risk assessment alongside metabolic markers?
Explore All Testing Options →Frequently Asked Questions
What causes gout?
Chronic hyperuricemia from insulin resistance impairing renal uric acid excretion, fructose metabolism producing uric acid through ATP degradation, excessive dietary purines, medications (diuretics), and renal insufficiency. It is fundamentally a metabolic disease, not just a dietary one.
Is gout caused by diet alone?
No. The primary driver is impaired renal excretion from insulin resistance. Approximately 90 percent of hyperuricemia is from under-excretion rather than overproduction. This is why gout is strongly associated with metabolic syndrome. Diet contributes but is not the primary mechanism in most patients.
Is gout connected to heart disease?
Yes. Hyperuricemia is an independent cardiovascular risk factor producing endothelial dysfunction, inflammasome activation, and vascular inflammation. The same insulin resistance driving gout also drives cardiovascular disease. Treating gout as a metabolic disease addresses both simultaneously.
Can gout be prevented without medication?
Many patients can prevent flares through insulin sensitization, fructose elimination, cherry concentrate, vitamin C, and adequate hydration. When these measures are insufficient to maintain uric acid below 6.0 mg/dL, urate-lowering medication is indicated alongside metabolic optimization.
Why does fructose cause gout?
Fructose phosphorylation in the liver rapidly depletes ATP, producing AMP that is degraded through the purine pathway to uric acid. This makes high-fructose corn syrup, sucrose, and fruit juice more potent drivers of hyperuricemia than dietary purines from meat.
How The Lamkin Clinic Approaches Gout
Clinical Perspective
When I see a gout patient, I see a metabolic patient. The uric acid in the toe is the same metabolic dysfunction that is producing the elevated triglycerides, the low HDL, the visceral fat, and the hypertension. The patient does not have five separate conditions. They have one metabolic disease with five downstream manifestations. When I measure fasting insulin, it is elevated in the vast majority. When I sensitize the insulin, the renal uric acid excretion improves, the triglycerides drop, the blood pressure improves, and the gout flares stop. One mechanism, one treatment, five conditions improved.
Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma
At The Lamkin Clinic, gout evaluation includes uric acid alongside comprehensive metabolic assessment: fasting insulin, HOMA-IR, triglyceride/HDL ratio, HbA1c, hs-CRP, renal function, and cardiovascular risk markers. Treatment addresses the metabolic disease producing the hyperuricemia: insulin sensitization, fructose elimination, cherry concentrate, vitamin C, and anti-inflammatory support alongside urate-lowering therapy when indicated. The goal is to treat the metabolic disease, not just the joint inflammation.
Related Conditions
Insulin ResistanceThe metabolic driver impairing renal uric acid excretion through URAT1 upregulation
→Cardiovascular Disease RiskHyperuricemia as an independent cardiovascular risk factor sharing metabolic drivers with gout
→HypertensionUric acid-mediated endothelial dysfunction and shared insulin resistance producing concurrent hypertension
→DyslipidemiaAtherogenic lipoprotein patterns from the same insulin resistance driving hyperuricemia
→Chronic InflammationNLRP3 inflammasome activation from urate crystal deposition producing systemic inflammation
→Type 2 DiabetesShared insulin resistance pathway producing both hyperuricemia and hyperglycemia
→Related Symptoms
Chronic FatigueMetabolic dysfunction and chronic inflammation producing persistent energy decline
→Obesity and Weight ManagementVisceral adiposity and insulin resistance as shared drivers of gout and metabolic syndrome
→Brain FogMetabolic inflammation and insulin resistance impairing cognitive function alongside gout
→Peripheral NeuropathyShared insulin resistance driving both uric acid and nerve damage through overlapping metabolic pathways
→Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.
Gout is a metabolic disease with identifiable and treatable drivers beyond uric acid reduction.
The Lamkin Clinic evaluates gout through comprehensive metabolic assessment to treat the insulin resistance, fructose burden, and inflammatory mechanisms producing hyperuricemia. Schedule a consultation.
Schedule a ConsultationMedical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Reference ranges and optimal targets may vary based on individual patient history, clinical presentation, and laboratory methodology. Schedule a consultation to discuss your specific results with Dr. Lamkin.